- CTIC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
CTI BioPharma (CTIC) S-3Shelf registration
Filed: 24 Oct 06, 12:00am
Exhibit 23.2
CONSENT OF GRANT THORNTON LLP,
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report, dated February 28, 2005, accompanying the consolidated financial statements and schedule of Cell Therapeutics, Inc. and subsidiaries appearing in the 2005 Annual Report of the Company to its shareholders on Form 10-K/A for the year ended December 31, 2005, which is incorporated by reference in this Registration Statement. We consent to the incorporation by reference in the Registration Statement of the aforementioned report and to the use of our name as it appears under the caption “Experts.”
/s/ Grant Thornton LLP | ||
Seattle, Washington | ||
October 19, 2006 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.